Quick Answer
ENDRA Life Sciences Inc. reported Stockholders Equity of $2.26 million for fiscal year 2025.
ENDRA Life Sciences Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.26M | -11.7% |
| 2024 | $2.56M | -54.8% |
| 2023 | $5.66M | -21.5% |
| 2022 | $7.20M | -33.2% |
| 2021 | $10.78M | +50.4% |
| 2020 | $7.17M | +50.6% |
| 2019 | $4.76M | -23.8% |
| 2018 | $6.25M | +18.4% |
| 2017 | $5.28M | +690.3% |
| 2016 | -$893.8K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $171.4K | -97.4% | -88.4% |
| June 30, 2025 | $1.47M | -83.6% | -16.0% |
| March 31, 2025 | $1.75M | -52.6% | -31.5% |
| December 31, 2024 | $2.56M | -54.8% | -61.2% |
| September 30, 2024 | $6.60M | +27.1% | -26.6% |
| June 30, 2024 | $8.99M | +29.8% | +143.2% |
| March 31, 2024 | $3.70M | -17.8% | -34.6% |
| December 31, 2023 | $5.66M | -21.5% | +8.9% |
- ENDRA Life Sciences Inc. showed a decrease of -11.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, ENDRA Life Sciences Inc.’s stockholders equity has grown by 352.9% (from -$893.8 thousand to $2.26 million).
- The most recent figure is from ENDRA Life Sciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: